On Tuesday, AbbVie earned an upgrade to its Relative Strength (RS) Rating, from 64 to 76.
Can You Really Time The Stock Market?
This proprietary rating measures market leadership by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the market's biggest winners typically have an RS Rating north of 80 as they begin their biggest price moves. See if AbbVie can continue to rebound and hit that benchmark.
AbbVie is working on a consolidation with a 218.66 entry. See if the stock can clear the breakout price in heavy trading.
Earnings grew 6% last quarter, up from -23% in the prior report. Revenue also increased, from 6% to 8%.
The company holds the No. 4 rank among its peers in the Medical-Ethical Drugs industry group. Phibro Animal Health is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Biotech And Pharmaceutical Industry And Stock News
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
